254 related articles for article (PubMed ID: 17204454)
1. Effect of serum and CTL on focal growth of human cytomegalovirus.
Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
[TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
Cho HI; Han H; Kim CC; Kim TG
J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
[TBL] [Abstract][Full Text] [Related]
3. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy of HCMV infection.
Kapp M; Tan SM; Einsele H; Grigoleit G
Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
[TBL] [Abstract][Full Text] [Related]
6. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
Boppana SB; Britt WJ
Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
[TBL] [Abstract][Full Text] [Related]
7. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.
Revello MG; Gerna G
Rev Med Virol; 2010 May; 20(3):136-55. PubMed ID: 20084641
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
[TBL] [Abstract][Full Text] [Related]
13. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
Gerna G; Lilleri D
Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
Yang R; Xia T; Xu G; Li Z; Ying Z; Xu X
Transplant Proc; 2008 Dec; 40(10):3500-4. PubMed ID: 19100424
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo.
Bego MG; Keyes LR; Maciejewski J; St Jeor SC
Arch Virol; 2011 Oct; 156(10):1847-51. PubMed ID: 21625978
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts.
Emery VC; Hassan-Walker AF; Burroughs AK; Griffiths PD
J Infect Dis; 2002 Jun; 185(12):1723-8. PubMed ID: 12085317
[TBL] [Abstract][Full Text] [Related]
17. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
[TBL] [Abstract][Full Text] [Related]
18. Induction of immunity against human cytomegalovirus.
Bennekov T; Spector D; Langhoff E
Mt Sinai J Med; 2004 Mar; 71(2):86-93. PubMed ID: 15029400
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection.
Meyer-König U; Vogelberg C; Bongarts A; Kampa D; Delbrück R; Wolff-Vorbeck G; Kirste G; Haberland M; Hufert FT; von Laer D
J Med Virol; 1998 May; 55(1):75-81. PubMed ID: 9580889
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and characterization of HLA-A * 0201 monomer and tetramer loaded with HCMV antigenic peptide].
He XH; Xu LH; Liu Y; Cai XC; Zeng YY
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):382-8. PubMed ID: 15971610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
